Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FluMist 60,000-Patient Phase IV Safety Study To Be Conducted With Kaiser

Jun 23 2003

• By The Pink Sheet

Related Content

Medimmune FluMist Indication Could Exclude Patients With Asthma

Jul 15 2002

FluMist Pharmacy Administration In 36 States Upon Approval – MedImmune

Mar 31 2003

FluMist Shedding Studies Needed To More Clearly Define Transmission Rate

Dec 23 2002

FluMist Comparison To Inactivated Vaccine Suggested By FDA Committee

Dec 23 2002

MedImmune FluMist Capacity Could Reach 20 Mil. Doses For 2004 Season

May 05 2003

Wyeth/Aviron FluMist Pulmonary Safety Requires More Analysis - FDA Cmte.

Jul 30 2001

FluMist Initial Indication May Exclude Patients Under Age Five

Nov 04 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window